Case Scenario 1 Discharge Summary Pathology Report Final Diagnosis: Oncology Consult

Similar documents
Case Scenario 1 Discharge Summary Pathology Report Final Diagnosis: Oncology Consult

Exercise. Discharge Summary

Quiz 1. Assign Race 1, Race 2 and Spanish Hispanic Origin to the following scenarios.

Testicular Malignancies /8/15

Case Scenario 1. 4/19/13 Bone Scan: No scintigraphic findings to suggest skeletal metastases.

Case Scenario 1 Worksheet. Primary Site C44.4 Morphology 8743/3 Laterality 0 Stage/ Prognostic Factors

Case Scenario 1: Thyroid

11/21/13 CEA: 1.7 WNL

Case Scenario 1. 7/13/12 Anterior floor of mouth biopsy: Infiltrating squamous cell carcinoma, not completely excised.

Case Scenario. 7/13/12 Anterior floor of mouth biopsy: Infiltrating squamous cell carcinoma, not completely excised.

1/25/13 Right partial nephrectomy followed by completion right radical nephrectomy.

Collecting Cancer Data: Testis 2/3/11. Collecting Cancer Data: NAACCR Webinar Series 1. Agenda. Fabulous Prizes

Case Scenario 1. Pathology report Specimen from mediastinoscopy Final Diagnosis : Metastatic small cell carcinoma with residual lymphatic tissue

Take Home Quiz 1 Please complete the quiz below prior to the session. Use the Multiple Primary and Histology Rules

Case Scenario 1. Discharge Summary

GUIDELINES ON TESTICULAR CANCER

Pancreas Case Scenario #1

Case Scenario 1. Pathology: Specimen type: Incisional biopsy of the glottis Histology: Moderately differentiated squamous cell carcinoma

FINE NEEDLE ASPIRATION OF ENLARGED LYMPH NODE: Metastatic squamous cell carcinoma

ASYMPTOMATIC COMPLEX TESTICULAR NEOPLASIA ASSOCIATED WITH ORCHIEPIDIDYMITIS. CASE REPORT

Testis. Protocol applies to all malignant germ cell and malignant sex cord-stromal tumors of the testis, exclusive of paratesticular malignancies.

EAU GUIDELINES ON TESTICULAR CANCER

Case Scenario 1. History

Case Scenario 1. 2/15/2011 The patient received IMRT 45 Gy at 1.8 Gy per fraction for 25 fractions.

Doppler ultrasound of the abdomen and pelvis, and color Doppler

Prostate Case Scenario 1

EAU GUIDELINES ON TESTICULAR CANCER

Case Scenario year-old white male presented to personal physician with dyspepsia with reflux.

Boot Camp Case Scenarios

Case Scenario #1 Larynx

Lung. 10/24/13 Chest X-ray: 2.9 cm mass like density in the inferior lingular segment worrisome for neoplasm. Malignancy cannot be excluded.

*OPERATIVE PROCEDURE. Serum tumour markers within normal limits S1.04 PRINCIPAL CLINICIAN

EAU GUIDELINES ON TESTICULAR CANCER

STAGING AND FOLLOW-UP STRATEGIES

Case Scenario 1: This case has been slightly modified from the case presented during the live session to add clarity.

Case Scenario 1: This case has been slightly modified from the case presented during the live session to add clarity.

5/26/16: CT scan of the abdomen showed a multinodular liver disease highly suspicious for metastasis and hydronephrosis of the right kidney.

Testicular germ cell tumors

Case Scenario 1 History and Physical 3/15/13 Imaging Pathology

Melanoma Case Scenario 1

Melanoma Case Scenario 1

Cardiff MRCS OSCE Courses Testicular Cancer

What is Testicular cancer?

Case Scenario 1. The patient has now completed his neoadjuvant chemoradiation and has been cleared for surgery.

Testicular Cancer. J. Richard Auman, MD. James J. Stark, MD. Jerry Singer, MD. September 19, 2008

Case Scenario 1. 1/2/13 History: 64-year-old white female presented with right leg swelling and redness, abdominal pain.

QUIZZES WITH ANSWERS FOR COLLECTING CANCER DATA: PHARYNX

NICaN Testicular Germ Cell Tumours SACT protocols

QUIZZES WITH ANSWERS FOR COLLECTING CANCER DATA: PHARYNX

Metastasis of Testicular Carcinoma in The Inguinal Region

Case Scenario 1. The patient agreed to a CT guided biopsy of the left upper lobe mass. This was performed and confirmed non-small cell carcinoma.

Running Title: Utility of HCG Washout in Cervical LND FNA

TESTICULAR CANCER Updated March 2016 by Dr. Safiya Karim (PGY-5 Medical Oncology Resident, University of Toronto)

Attachment #2 Overview of Follow-up

Teratocarcinoma In A Young Boy- An Unusual Presentation

Attachment #2 Overview of Follow-up

Case Scenario 1. 1/2/13 History: 64-year-old white female presented with right leg swelling and redness, abdominal pain.

GUIDELINES ON TESTICULAR CANCER

Testicular Cancer: Questions and Answers. Testicular cancer is a disease in which cells become malignant (cancerous) in one or both testicles.

Note: The cause of testicular neoplasms remains unknown

Mixed Germ Cell Testis Tumor Presenting with Massive Lung Metastasis

Please complete prior to the webinar. HOSPITAL REGISTRY WEBINAR FEMALE REPRODUCTIVE SYSTEM EXERCISES CASE 1: FEMALE REPRODUCTIVE

BENIGN & MALIGNANT TESTIS DISEASES. Gary J. Faerber, M.D. Associate Professor, Dept of Urology March 2009 OBJECTIVES

-The cause of testicular neoplasms remains unknown

Testicular Cancer. Regional Follow-up Guidelines

Regressed Testicular Seminoma with Extensive Metastases. S Andhavarapu, B Low, J Raj, S Skinner, J Armenta-Corona

Pancreas Quizzes c. Both A and B a. Directly into the blood stream (not using ducts)

molecular brothers David Pfisterer Lucerne, Switzerland ESIM 2011

Guidelines on Testicular Cancer

Histology Coding ANSWERS

MULTIDISCIPLINARY GENITOURINARY ONCOLOGY COURSE

Testis /10/2019. Please submit all questions concerning the webinar content through the Q&A panel.

Citation for published version (APA): Lutke Holzik, M. F. (2007). Genetic predisposition to testicular cancer s.n.

MPH Quiz. 1. How many primaries are present based on this pathology report? 2. What rule is this based on?

Case Scenarios. 12/28/12 MRI Liver: multiple focal arterially enhancing liver lesions, indeterminate. Repeat MRI in 4 months.

Corporate Medical Policy

Male Genital Cancers in the US in Frequency of Types

Prognostic factors of genitourinary tumors: Do we have to care?

Uncommon secondary tumour of the stomach

Male genital tract tumors. SiCA. Division of Urology, Department of Surgery, Faculty of Medicine Siriraj Hospital.

Extratesticular Extension of Germ Cell Tumors Preferentially Occurs at the Hilum

Exercise 15: CSv2 Data Item Coding Instructions ANSWERS

Lymphoma Case Scenario 1

Case Report Primary Malignancy in a Supernumerary Testicle Presenting as a Large Pelvic Mass

Pathology: Grade 1 infiltrating ductal carcinoma with associated DCIS, Lymphvascular invasion present. ER+, PR+. Her 2/ IHC 1+, negative

Abstracting Upper GI Cancer Incidence and Treatment Data Quiz 1 Multiple Primary and Histologies Case 1 Final Pathology:

Testicular Cancer. What is cancer?

Radiation Oncology MOC Study Guide

Prostate Overview Quiz

Kidney Case 1 SURGICAL PATHOLOGY REPORT

Resection of retroperitoneal residual mass after chemotherapy in patients with nonseminomatous testicular cancer

Q&A. Overview. Collecting Cancer Data: Prostate. Collecting Cancer Data: Prostate 5/5/2011. NAACCR Webinar Series 1

Germ Cell Tumors. Karim Fizazi, MD, PhD Institut Gustave Roussy, France

Case Report Seminoma Presenting as Renal Mass, Inferior Vena Caval Thrombus, and Regressed Testicular Mass

A patient with recurrent bladder cancer presents with the following history:

Multiple Primary Quiz

Ultrasound of malignant testicular lesions. Arne Hørlyck Department of Radiology Aarhus University Hospital, Skejby

Page 1 of 17 TABLE OF CONTENTS

GUIDELINES FOR THE MANAGEMENT OF UROLOGICAL CANCER

Case Report A Literature Review and Case Report of Metastatic Pure Choriocarcinoma

Transcription:

Case Scenario 1 Discharge Summary A 31-year-old Brazilian male presented with a 6 month history of right-sided scrotal swelling. Backache was present for 2 months and a history of right epididymitis was present for 8 months. The patient presented with the following elevated tumor markers: Alpha-fetoprotein: 2628 ng/ml (normal range 0-15 ng/ml), beta-hcg: 696 IU/ml (normal range 2-5 IU/ml), LDH: 936 U/L (normal range 300-600 U/L). Ultrasound of the scrotum revealed a large descended right testis swelling characterized by scarce cystic elements and calcifications. CT scan of the abdomen was negative. Both Chest x-ray and CT scan of the chest were negative as well. The patient underwent right-sided radical orchiectomy on August 5, 2014. Pathology Report Specimen: Right testicle Gross Description: The specimen is received in a formalin-filled container labeled with the patient's name. The specimen is designated as "right testicle" and consists of a testicle with attached spermatic cord, which together weighs 65 gm. The spermatic cord measures 8.0 cm in length by 2.0 cm in diameter. The tunica vaginalis is baggy and has a stringy appearance. The outer portion of the testicle measures 7.0 x 3.5 x 3.5 cm. Prior to dissection, the entire outer surface is marked with black ink. The specimen is then bisected. The tunica vaginalis is noted to contain a small amount of straw-colored fluid. The testicle measures 4.3 x 3.0 x 3.0 cm. The testicular parenchyma showed a single tumor. The tumor is firm, yellow-pink-tan with areas of focal hemorrhage and measures 2.7 x 1.7 x 1.2 cm. The tumor invades through the tunica albuginea and into the tunica vaginalis, but does not appear to extend to the spermatic cord. The epididymis measures 3.0 cm in length by up to 1.0 cm in diameter. The remaining testicular parenchyma appears normal. Final Diagnosis: Right testicle radical orchiectomy: A single tumor measuring 2.7 cm composed of 80% embryonal carcinoma and 20% seminoma. Definite lymphovascular invasion is not identified. The background testicular parenchyma shows intratubular germ cell neoplasia. Oncology Consult Three weeks post orchiectomy serum tests showed a normalized AFP, and Beta-hCG, but the LDH continues to be elevated (920). He began a chemotherapy regimen of BEP (Bleomycin, Etoposide, and Cisplatin) on 9/28/14. Serum markers normalized upon completion of the 1st round of chemotherapy. After the 2nd cycle LDH became elevated again. The patient the patient had a CT scan of the chest and abdomen that revealed a retroperitoneal mass and multiple lung metastases.

Case Scenario 1 Worksheet Primary Site Morphology Grade Stage/ Prognostic Factors CS Tumor Size CS SSF 9 CS Extension CS SSF 10 CS Tumor Size/Ext Eval CS SSF 11 CS Lymph Nodes CS SSF 12 CS Lymph Nodes Eval CS SSF 13 Regional Nodes Positive CS SSF 14 988 Regional Nodes Examined CS SSF 15 CS Mets at Dx CS SSF 16 CS Mets Eval CS SSF 17 988 CS SSF 1 988 CS SSF 18 988 CS SSF 2 988 CS SSF 19 988 CS SSF 3 988 CS SSF 20 988 CS SSF 4 CS SSF 21 988 CS SSF 5 CS SSF 22 988 CS SSF 6 CS SSF 23 988 CS SSF 7 CS SSF 24 988 CS SSF 8 CS SSF 25 988 Summary Stage 2000 Clinical AJCC TNM Stage Diagnostic Staging Procedure Surgery Codes Surgical Procedure of Primary Site Scope of Regional Lymph Node Surgery Surgical Procedure/ Other Site Systemic Therapy Codes Chemotherapy Hormone Therapy Immunotherapy Hematologic Transplant/Endocrine Procedure Systemic/Surgery Sequence Pathologic AJCC TNM Stage Treatment Radiation Codes Radiation Treatment Volume Regional Treatment Modality Regional Dose Boost Treatment Modality Boost Dose Number of Treatments to Volume Reason No Radiation Radiation/Surgery Sequence

Case Scenario 2 Discharge Summary A 26-year-old male presented with a 6 month history of left-sided scrotal swelling. Backache was present for 2 months and a history of left epididymitis was present for 8 months. The patient presented with the following tumor markers: Alpha-Fetoprotein: 2 ng/ml (normal range 0-15 ng/ml), beta-hcg: 149 IU/ml (normal range 2-5 IU/ml), LDH: 875 U/L (normal range 300-600 U/L). Ultrasound of the scrotum revealed large descended left testis swelling characterized by scarce cystic elements and calcifications. CT scan of the abdomen showed nodular metastasis involving the interaortocaval, precaval, and left para-aortic lymph nodes. The largest lymph node measured 3.2 cm. Both chest x-ray and CT scan of the chest showed no lymphadenopathy. The patient underwent left-sided radical orchiectomy on November 12, 2014. Pathology Report Specimen: Left testicle Gross Description: The specimen is received in a formalin-filled container labeled with the patient's name. The specimen is designated as "left testicle" and consists of a testicle with attached spermatic cord, which together weighs 65 gm. The spermatic cord measures 8.0 cm in length by 2.0 cm in diameter. The tunica vaginalis is baggy and has a stringy appearance. The outer portion of the testicle measures 7.0 x 3.5 x 3.5 cm. Prior to dissection, the entire outer surface is marked with black ink. The specimen is then bisected. The tunica vaginalis is noted to contain a small amount of straw-colored fluid. The testicle measures 4.3 x 3.0 x 3.0 cm. The testicular parenchyma displays a tumor. The tumor measures 3.2 x 2.1 x 2.0 cm and is soft and pink. The tumor extends to, but not through the tunica albuginea. The tumor does not appear to extend to the spermatic cord. The epididymis measures 3.0 cm in length by up to 1.0 cm in diameter. The remaining testicular parenchyma appears normal. Final Diagnosis: Left testicle, radical orchiectomy: Single nodule measuring 3.2 cm. The tumor nodule is composed of seminoma. Definite lymphovascular invasion is not identified. The nodule is confined to the testis without invasion into the epididymis or through the tunica albuginea. The spermatic cord margin is free of malignancy. The background testicular parenchyma shows intratubular germ cell neoplasia. Radiation Oncology Consult The patient presented post orchiectomy with normal AFP and B-hCG. However, the LDH continues to be elevated at 720. Using IMRT the patient received 20 Gy to the para-aortic and left iliac lymph nodes (modified dog leg). He had a daily dosage of 2Gy over 10 days followed by a boost of 16 Gy (2Gy over 8 days). Following completion of radiation the patient had normalized serum levels.

Case Scenario 2 Worksheet Primary Site Morphology Grade Stage/ Prognostic Factors CS Tumor Size CS SSF 9 CS Extension CS SSF 10 CS Tumor Size/Ext Eval CS SSF 11 988 CS Lymph Nodes CS SSF 12 988 CS Lymph Nodes Eval CS SSF 13 Regional Nodes Positive CS SSF 14 988 Regional Nodes Examined CS SSF 15 CS Mets at Dx CS SSF 16 CS Mets Eval CS SSF 17 988 CS SSF 1 988 CS SSF 18 988 CS SSF 2 988 CS SSF 19 988 CS SSF 3 988 CS SSF 20 988 CS SSF 4 CS SSF 21 988 CS SSF 5 CS SSF 22 988 CS SSF 6 CS SSF 23 988 CS SSF 7 CS SSF 24 988 CS SSF 8 CS SSF 25 988 Summary Stage 2000 Clinical AJCC TNM Stage Diagnostic Staging Procedure Surgery Codes Surgical Procedure of Primary Site Scope of Regional Lymph Node Surgery Surgical Procedure/ Other Site Systemic Therapy Codes Chemotherapy Hormone Therapy Immunotherapy Hematologic Transplant/Endocrine Procedure Systemic/Surgery Sequence Pathologic AJCC TNM Stage Treatment Radiation Codes Radiation Treatment Volume Regional Treatment Modality Regional Dose Boost Treatment Modality Boost Dose Number of Treatments to Volume Reason No Radiation Radiation/Surgery Sequence

Case Scenario 3 8/4/14 History & Physical: Patient is a 30-year-old white male with swelling in the right testicle and inguinal area for about a month. Surgery and appointment with oncologist scheduled. 7/24/14 Testicular ultra-sound: 3 cm mass of the right testicle; normal left testicle. 7/24/14 Pelvic ultrasound: 2.5 cm malignant adenopathy of right interaortocaval node; 2 cm right pelvic node mass with malignant adenopathy. 8/4/14 Chest x-ray: Normal. 8/18/14 Right inguinal radical orchiectomy pathology: 3 cm right testicular tumor, mixed embryonal carcinoma and teratoma with lymph-vascular invasion, involving the tunica vaginalis and para-testicular soft tissues. Margins of resection are clear. There is no involvement of the spermatic cord. Lab Work 8/4/14 AFP: 850 ng/ml, elevated 8/4/14 hcg: 3,500 miu/ml, elevated 8/4/14 LDH: 200; 172 is upper limit of normal 8/20/14 AFP: 10 ng/ml, within normal limits 8/20/14 hcg: 20 miu/nl, within normal limits 8/20/14 LDH: 100 U/L, within normal limits 9/18/14 Oncology: Patient started chemotherapy today with the first of 3 cycles of BEP.

Case Scenario 3 Worksheet Primary Site Morphology Grade Stage/ Prognostic Factors CS Tumor Size CS SSF 9 CS Extension CS SSF 10 CS Tumor Size/Ext Eval CS SSF 11 988 CS Lymph Nodes CS SSF 12 988 CS Lymph Nodes Eval CS SSF 13 Regional Nodes Positive CS SSF 14 988 Regional Nodes Examined CS SSF 15 CS Mets at Dx CS SSF 16 CS Mets Eval CS SSF 17 988 CS SSF 1 988 CS SSF 18 988 CS SSF 2 988 CS SSF 19 988 CS SSF 3 988 CS SSF 20 988 CS SSF 4 CS SSF 21 988 CS SSF 5 CS SSF 22 988 CS SSF 6 CS SSF 23 988 CS SSF 7 CS SSF 24 988 CS SSF 8 CS SSF 25 988 Summary Stage Clinical AJCC TNM Stage Diagnostic Staging Procedure Surgery Codes Surgical Procedure of Primary Site Scope of Regional Lymph Node Surgery Surgical Procedure/ Other Site Systemic Therapy Codes Chemotherapy Hormone Therapy Immunotherapy Hematologic Transplant/Endocrine Procedure Systemic/Surgery Sequence Pathologic AJCC TNM Stage Treatment Radiation Codes Radiation Treatment Volume Regional Treatment Modality Regional Dose Boost Treatment Modality Boost Dose Number of Treatments to Volume Reason No Radiation Radiation/Surgery Sequence